Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVASTIN /01555201: 41 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
41
Total FAERS Reports
9 (22.0%)
Deaths Reported
11
Hospitalizations
41
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities

First Report: 2004 · Latest Report: 20140319

What Are the Most Common AVASTIN /01555201 Side Effects?

#1 Most Reported
Malignant neoplasm progression
9 reports (22.0%)
#2 Most Reported
Diarrhoea
8 reports (19.5%)
#3 Most Reported
Fatigue
6 reports (14.6%)

All AVASTIN /01555201 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Malignant neoplasm progression 9 22.0% 4 2
Diarrhoea 8 19.5% 0 3
Death 6 14.6% 6 0
Fatigue 6 14.6% 2 1
Nausea 5 12.2% 1 2
Rash 5 12.2% 0 2

Who Reports AVASTIN /01555201 Side Effects? Age & Gender Data

Average age: 59.9 years. Most reports from: US. View detailed demographics →

Is AVASTIN /01555201 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2004 1 0 0
2009 2 0 1
2011 2 1 1
2012 4 1 1
2013 12 2 4
2014 7 2 3

View full timeline →

What Is AVASTIN /01555201 Used For?

IndicationReports
Non-small cell lung cancer 8
Product used for unknown indication 8
Lung neoplasm malignant 5

Official FDA Label for AVASTIN /01555201

Official prescribing information from the FDA-approved drug label.